查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602727

解剖病理学测试市场：按组成部分、按应用划分 - 2025-2030 年全球预测

Anatomic Pathology Testing Market by Component (Consumables, Instruments, Services), Application (Disease Diagnosis, Drug Discovery & Development) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年解剖病理检测市值为424.3亿美元，预计2024年将达到450.3亿美元，复合年增长率为6.22%，2030年将达到647.4亿美元，预计将达到1000万美元。

解剖病理学检测是医学诊断领域的重要组成部分，主要透过检查组织样本来诊断疾病、指南治疗和进行研究。对解剖病理学测试的需求在于其无与伦比的能力，能够提供对有效患者照护至关重要的准确诊断信息，特别是在肿瘤学、感染疾病和器官移植评估方面。主要应用是切片检查、外科病理学和细胞病理学，最终用户是医院、诊断实验室和学术研究机构。该市场受到慢性病患病率上升、人口老化、医疗意识增强以及数位病理学和人工智慧整合等技术进步等因素的推动。个人化医疗需求的快速成长以及促进标靶治疗的新型生物标记的开发正在创造关键的成长机会。扩大远距病理学服务也有潜力，特别是在偏远地区和专家很少的国家。然而，先进诊断技术的高成本、监管障碍和熟练病理学家短缺等挑战可能会阻碍市场扩张。此外，资料隐私问题和对强大IT基础设施的需求是进一步的限制因素。适合创新和研究的领域包括数位病理学的进步、人工智慧主导的诊断工具以及开发自动化病理测试设备以提高准确性和效率。科技公司和医疗保健提供者之间的合作可以创建简化工作流程的整合平台。随着解剖病理学领域的发展，专注于缩短週转时间、提高诊断准确性和整合新技术对于寻求抓住成长机会的相关人员至关重要。该市场的特点是技术活力高、竞争激烈，要求相关人员采用颠覆性技术和策略伙伴关係来确保竞争。

主要市场统计
基准年[2023] 424.3亿美元
预测年份 [2024] 450.3亿美元
预测年份 [2030] 647.4亿美元
复合年增长率（%） 6.22%

市场动态：揭示快速发展的解剖病理学测试市场的关键市场洞察

供需的动态交互作用正在改变解剖病理学测试市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 由于饮食习惯和生活方式的改变，抗癌药物临床试验数量增加
    • 个人化医疗日益受到关注
    • 临床中心对改善诊断程序的需求迅速增加
  • 市场限制因素
    • 缺乏熟练的专业人员
  • 市场机会
    • 解剖病理学测试的进展提供有针对性的覆盖
    • 增强对研究恶性和肿瘤发展的生物标记特异性病理测试和程序的信心
  • 市场问题
    • 政府严格的规章制度

波特五力：驾驭解剖病理学测试市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对解剖病理学检测市场的影响

外部宏观环境因素在塑造解剖病理学测试市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解解剖病理学检测市场的竞争格局

解剖病理学测试市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵：解剖病理学测试市场供应商的绩效评估

FPNV 定位矩阵是评估解剖病理学测试市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製解剖病理学测试市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对解剖病理学测试市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 由于饮食习惯和生活方式的改变，与癌症治疗相关的临床试验正在增加。
      • 个人化医疗日益受到关注
      • 临床中心对改善诊断程序的需求迅速增加
    • 抑制因素
      • 缺乏熟练的专业人员
    • 机会
      • 解剖病理学测试的进展提供有针对性的覆盖
      • 越来越依赖使用生物标记的病理测试和治疗来研究恶性和肿瘤形成
    • 任务
      • 政府严格的规章制度
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章解剖病理学测试市场：按组成部分

  • 介绍
  • 消耗品
  • 装置
  • 服务

第七章解剖病理学测试市场：依应用分类

  • 介绍
  • 疾病诊断
  • 药物发现与开发

第八章 北美、南美洲解剖病理检测市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太解剖病理检测市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲/中东/非洲解剖病理检测市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Becton, Dickinson and Company
  • Cardinal Health, Inc.
  • Danaher Corporation
  • Diapath SpA
  • Digipath, Inc.
  • Enzo Biochem, Inc.
  • Epic Sciences
  • Epredia
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Quest Diagnostics Incorporated
  • Sakura Finetek USA, Inc.
Product Code: MRR-436901066173

The Anatomic Pathology Testing Market was valued at USD 42.43 billion in 2023, expected to reach USD 45.03 billion in 2024, and is projected to grow at a CAGR of 6.22%, to USD 64.74 billion by 2030.

Anatomic pathology testing is a vital component of the medical diagnostics field, focusing on the examination of tissue samples to diagnose diseases, guide treatment, and conduct research. The necessity of anatomic pathology testing lies in its unparalleled ability to deliver precise diagnostic information essential for effective patient care, especially in oncology, infectious diseases, and organ transplant evaluations. The primary applications involve biopsy, surgical pathology, and cytopathology, with end-users comprising hospitals, diagnostic labs, academic and research institutes. The market is driven by factors like the rising prevalence of chronic diseases, the aging population, increasing healthcare awareness, and technological advancements such as digital pathology and AI integration. Key growth opportunities are emerging due to the surging demand for personalized medicine and the development of novel biomarkers that facilitate targeted therapy. There is also a potential in expanding telepathology services, especially in remote areas or countries with fewer specialized professionals. However, challenges such as the high cost of advanced diagnostic technologies, regulatory hurdles, and a shortage of skilled pathologists may inhibit market expansion. Furthermore, data privacy concerns and the need for robust IT infrastructure pose additional constraints. The best areas for innovation and research include advancements in digital pathology, AI-driven diagnostic tools, and the development of automated pathology equipment to improve accuracy and efficiency. Collaborations between technology firms and healthcare providers can enable the creation of integrated platforms that streamline workflow processes. As the anatomic pathology landscape evolves, focus on improving turnaround times, enhancing diagnostic accuracy, and integrating new technologies are crucial for stakeholders aiming to seize growing opportunities. The market is characterized by high technological dynamism and competitive intensity, urging stakeholders to adopt disruptive technologies and strategic partnerships to secure a competitive edge.

KEY MARKET STATISTICS
Base Year [2023] USD 42.43 billion
Estimated Year [2024] USD 45.03 billion
Forecast Year [2030] USD 64.74 billion
CAGR (%) 6.22%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anatomic Pathology Testing Market

The Anatomic Pathology Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in the number of clinical trials pertaining to cancer drugs due to changes in food habits and lifestyle
    • Increasing focus on personalized medicine
    • Surge in demand to improve the diagnostic procedure in clinical centers
  • Market Restraints
    • Unavailability of skilled professionals
  • Market Opportunities
    • Advances in anatomic pathology testing providing targeted coverage
    • Growth in reliance on biomarkers-based pathology tests and procedures for exploring malignancy and tumorigenesis
  • Market Challenges
    • Strigent rules and regulations by the government

Porter's Five Forces: A Strategic Tool for Navigating the Anatomic Pathology Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anatomic Pathology Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anatomic Pathology Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anatomic Pathology Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anatomic Pathology Testing Market

A detailed market share analysis in the Anatomic Pathology Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anatomic Pathology Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anatomic Pathology Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Anatomic Pathology Testing Market

A strategic analysis of the Anatomic Pathology Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Anatomic Pathology Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Company, Cardinal Health, Inc., Danaher Corporation, Diapath S.p.A., Digipath, Inc., Enzo Biochem, Inc., Epic Sciences, Epredia, F. Hoffmann-La Roche AG, Hologic, Inc., Laboratory Corporation of America Holdings, Merck KGaA, Quest Diagnostics Incorporated, and Sakura Finetek USA, Inc..

Market Segmentation & Coverage

This research report categorizes the Anatomic Pathology Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Consumables, Instruments, and Services.
  • Based on Application, market is studied across Disease Diagnosis and Drug Discovery & Development.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the number of clinical trials pertaining to cancer drugs due to changes in food habits and lifestyle
      • 5.1.1.2. Increasing focus on personalized medicine
      • 5.1.1.3. Surge in demand to improve the diagnostic procedure in clinical centers
    • 5.1.2. Restraints
      • 5.1.2.1. Unavailability of skilled professionals
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in anatomic pathology testing providing targeted coverage
      • 5.1.3.2. Growth in reliance on biomarkers-based pathology tests and procedures for exploring malignancy and tumorigenesis
    • 5.1.4. Challenges
      • 5.1.4.1. Strigent rules and regulations by the government
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Anatomic Pathology Testing Market, by Component

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments
  • 6.4. Services

7. Anatomic Pathology Testing Market, by Application

  • 7.1. Introduction
  • 7.2. Disease Diagnosis
  • 7.3. Drug Discovery & Development

8. Americas Anatomic Pathology Testing Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Anatomic Pathology Testing Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Anatomic Pathology Testing Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Agilent Technologies Inc.
  • 3. Becton, Dickinson and Company
  • 4. Cardinal Health, Inc.
  • 5. Danaher Corporation
  • 6. Diapath S.p.A.
  • 7. Digipath, Inc.
  • 8. Enzo Biochem, Inc.
  • 9. Epic Sciences
  • 10. Epredia
  • 11. F. Hoffmann-La Roche AG
  • 12. Hologic, Inc.
  • 13. Laboratory Corporation of America Holdings
  • 14. Merck KGaA
  • 15. Quest Diagnostics Incorporated
  • 16. Sakura Finetek USA, Inc.

LIST OF FIGURES

  • FIGURE 1. ANATOMIC PATHOLOGY TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ANATOMIC PATHOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ANATOMIC PATHOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANATOMIC PATHOLOGY TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANATOMIC PATHOLOGY TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM ANATOMIC PATHOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ANATOMIC PATHOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. ANATOMIC PATHOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2023